Abstract:Purpose/Objective(s) Recent research has categorized the genetic make-up of head and neck squamous cell cancers (HNSCC) at initial presentation. However, despite advances in treatment, up to 50% of patients develop a recurrent/metastatic (R/M) disease, with a significant decline in survival at that time. Here, we aim to analyze the genetic composition of patients with R/M HNSCC to establish the most frequent alterations in this population and determine if there are associations with survival. Materials/Methods We performed an IRB-approved retrospective analysis of patients with confirmed recurrences of head and neck cancer after treatment for curative intent. We collected clinical data from one institution's electronic health records. Patients were grouped into cancer locations [oropharynx, oral cavity, hypopharynx, larynx, nasopharynx]. Targeted DNA sequencing of the tumor samples was performed by Tempus. R square analysis was done to compare tumor genetic make-up. Results To date, a total of 44 patients with head and neck cancer recurrences were included in the analysis. 43.5% of patients had oral cavity cancer, and 32.6% of patients had oropharynx cancer. Seventeen patients (39%) were p16 positive. The median age at the time of diagnosis was 62.5 years (range 36-82), and the majority of patients were male (n=28, 64%). Twenty-four patients (54%) had a current or former smoking history. The median overall survival time was 721 days from the date of diagnosis. The median disease-free survival was 198 days. Survival rate of the entire cohort was 27.2% at the time of analysis. The most common mutation seen in the cohort was TP53, which was present in 29 patients (65%) and was associated with worse overall and disease-free survival. TERT and CDKN2A mutations were seen in 16 patients (36%), but were not associated with outcomes in this small sample size. Notably, both TERT and CDKN2A mutations are less common for the primary HNSCC diagnosis. Additional alterations were noted in PIK3CA (found in 20% of patients) and LRP1B (found in 9% of patients); while the former is associated with better overall survival, the latter was strongly associated with worse disease-free survival. Conclusion In the analysis of the R/M HNSCC cases, we identified genomic alterations similar to those found during primary diagnosis. While HNSCC cancers are genetically heterogeneous, alterations in TP53 remain the most commonly noted. R/M HNSCC populations commonly have CDKN2A and TERT mutations that are rarely found in primary diagnosis. In addition, mutations in LRP1B were associated with worse disease-free survival. Further analysis is ongoing to define the correlation between the mutational landscape of our patients and their response to therapy.

Karyotypic Evolution and Tumor Progression in Head and Neck Squamous Cell Carcinomas.

Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck

Molecular characterization of the evolution of premalignant lesions in the upper aerodigestive tract

Pervasive chromosomal instability and karyotype order in tumour evolution

Progression Analysis of Lung Squamous Cell Carcinomas by Comparative Genomic Hybridization

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma

Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma

Cytogenetic and Fluorescence in Situ Hybridization Characterization of Clonal Chromosomal Aberrations and CCND1 Amplification in Esophageal Carcinomas

Chromosomal abnormalities associated with neck nodal metastasis in nasopharyngeal carcinoma.

Tumor Genomics and the Association with Survival in Recurrent/metastatic Head and Neck Cancer Patients

Genomic Alterations in Head and Neck Squamous Cell Carcinoma Determined by Cancer Gene-Targeted Sequencing.

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Single cell deciphering of progression trajectories of the tumor ecosystem in head and neck cancer

Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness

High-Resolution Array Based Heterogeneity And Clonality Profiling Of Oral Squamous Cell Carcinoma: Genetic Relationship Between Metastatic Primary Tumor And The Paired Lymph Node Metastases

Increased Chromosomal Instability Characterizes Metastatic Renal Cell Carcinoma.

[Clinical Significance of Continuous Karyotyping in Myelodysplastic Syndromes].

Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma

Comparative Genomic Hybridization Study of Primary Non-Hodgkin's Lymphoma of Head and Neck

Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC)

Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres